Příspěvek klinického mikrobiologa k mezinárodnímu konsenzu EHRA(International consensus EHRA from the perspective of a clinical microbiologist)

Milan Kolář

Cor Vasa 2020, 62(3):279 | DOI: 10.33678/cor.2020.070  

Role of transthoracic echocardiography in the detection of atrial septal aneurysm and intracardial shunts of PFO type in ambulatory practice

Jan Pavlovič, Jana Rubáčková Popelová, Martin Mates

Cor Vasa 2020, 62(3):251-256 | DOI: 10.33678/cor.2020.013  

Aims: This study evaluates the usage of TTE as a screening method to detect ASA as is demonstrated on the population of patients examined within the period of one year. Methods: From January 2019 to January 2020, 769 patients underwent TTE on outpatient basis. 87% of these with either good or very good image quality were analyzed for the presence of ASA. In the presence of ASA, and in the case of patient's interest, CTTE was performed. Results: We have identified 80 patients with ASA out of which 37 underwent contrast examination. 34 of these were positive for the presence of R-L shunt. Around 18% of patients with ASA exhibited symptoms, which were...

Serum chemerin correlated to the SYNTAX score in obese Egyptian patients with coronary artery disease

Noha Hassanin, Yasser Sharaf, Mervat Al-Anany, Essam Faisal

Cor Vasa 2020, 62(3):257-266 | DOI: 10.33678/cor.2019.082  

Background: Chemerin is a newly discovered adipokine which has been found closely associated with obesity, metabolic syndrome, and inflammatory status. However, it remains unclear whether chemerin is involved in patients with cardiovascular disease. Objective: The aim of the study was to examine whether serum chemerin levels are associated with the severity of coronary artery disease (CAD) in obese Egyptian patients. Material and methods: The study enrolled 100 patients who underwent coronary angiography for clinically indicated reasons classified according to body mass index (BMI) into two groups, 50 patients (group A) with BMI (≥30 kg/m²)...

(Transthyretin amyloidosis)

Renáta Aiglová, Miloš Táborský, Pavla Flodrová, Alexander Schee

Cor Vasa 2020, 62(3):267-271 | DOI: 10.33678/cor.2020.019  

Transthyretin amyloidosis is a disease that has been considered as rare. However, recent studies have shown that this disorder is underdiagnosed. Clinical manifestation of this disease is variable, cardiac impairment can be isolated, but often manifestation of this disease is also polyneuropathy. Diagnostic and treatment have recently changed. New drugs that affect positively not only mortality, but also quality of life, have been introduced to clinical practice.

(Complex approach towards patients with hypertrophic cardiomyopathy and indications to genetic testing)

Jiří Bonaventura, Alice Krebsová, Veronika Zoubková, Pavel Votýpka, Petra Peldová, Jana Petřková, Josef Kautzner, Milan Macek Jr., Josef Veselka

Cor Vasa 2020, 62(3):272-278 | DOI: 10.33678/cor.2020.023  

Hypertrophic cardiomyopathy (HCM) is one of the most frequent inherited cardiac disorders with an estimated prevalence of 1 in 500 up to 1 in 200 individuals. The phenotypic heterogeneity of HCM corresponds with the marked heterogeneity in the underlying genotype. Multidisciplinary approach to HCM patients is needed and includes the collaboration of cardiologists with molecular genetics, clinical genetics, paediatric cardiologists and other specialists. Advances in contemporary DNA-sequencing methodology make gene-based diagnosis increasingly feasible in routine clinical practice. It allows rapid analysis of large multigene testing panels (e.g. cardiovascular...

Contained rupture of an infected abdominal aneurysm eroding into the L4 vertebra in a patient after aorto-femoral reconstruction

Róbert Novotný, Libor Janoušek, Jaroslav Chlupáč, Karel Sutoris, Michal Kudla, Jiří Froněk

Cor Vasa 2020, 62(3):315-318 | DOI: 10.33678/cor.2019.084  

Introduction: Chronic contained rupture of the abdominal aneurysm (AAA) eroding into the vertebrae is relatively uncommon. One of its manifestations besides pulsatile abdominal mass can be unspecific low back pain. Case presentation: A 70-year-old male patient after right aorto-femoral prosthetic bypass (RAFB) eleven years ago was referred to our center with non-specific lower back pain lasting for the past 12 hours. Computed tomography angiography (CTA) revealed contained ruptured 57 × 63 mm AAA protruded into the L4 vertebra. The patient was scheduled for an open repair through a midline laparotomy. Microbiological examination from the AAA sack revealed...

(Aortoesophageal fistula as a fatal complication of dilated descending aorta in chronic aortic dissection)

Kamila Blechová, Jiří Knot, Arpád Szabó

Cor Vasa 2020, 62(3):319-324 | DOI: 10.33678/cor.2019.073  

Aortoesophageal fistula (AEP) is defined as a pathological communication between the aorta and the esophagus. This condition is associated with high mortality and morbidity. AEP is characterized by a set of symptoms called the Chiari Triad. Typical symptoms are chest pain or dysphagia, gastrointestinal bleeding, and massive hematemesis occurring after a symptom-free period. There are two types of AEP - primary and secondary. The most common causes of the primary AEP are thoracic aortic aneurysms, foreign bodies swallowing, esophagus tumors, traumatic aortic injuries, and TB. The secondary AEP arises as a complication of thoracic endovascular aortic...

Acute lower limb ischemia secondary to diffuse peritonitis

Peter Berek, Іvan Kopolovets, Vladimir Sihotsky

Cor Vasa 2020, 62(3):325-328 | DOI: 10.33678/cor.2019.070  

Background: Acute lower limb ischemia is generally caused by embolism, thrombosis, and traumatic injuries. However, patients with acute limb ischemia secondary to other underlying disease constitute a separate group. Case presentation: In this paper, we describe a case report of a 72-year-old woman, who was hospitalized with acute right lower limb ischemia to the Clinic of Vascular Surgery. According to past medical history, one day before hospitalization, the patient was examined by a surgeon for abdominal pain without signs of peritonitis. An abdominal ultrasound that did not reveal any pathology was performed; laboratory tests, that indicated an...

Acute ECG ST-segment elevation as infero-lateral myocardial infarction in a patient with pulmonary embolism

Pinar Dogan, Murat Gul, Sinan Inci

Cor Vasa 2020, 62(3):329-331 | DOI: 10.33678/cor.2019.056  

Pulmonary embolism and ST-elevation myocardial infarction are both common causes of cardiovascular emergency which may rapidly lead to hemodynamic deterioration. A 70-year-old female brought to emergency department in cardiac arrest. The electrocardiogram (ECG) revealed sinus rhythm with right bundle branch block, ST-elevations in inferolateral leads. Her coronary angiogram showed non-obstructive coronary artery disease with a few plaques. A CT pulmonary angiogram showed subtotal occlusion of left main pulmonary artery and multiple filling defects on bilateral pulmonary distal segments. This report emphasizes that acute PE should be suspected in every...

Patent foramen ovale and paradoxical coronary artery embolism: rare event with great clinical relevance

Claudia Morabito, Michele Scarano, Eugenio Genovesi, Vittoria Vaccaro, Giulia Laterra, Pasquale Crea, Giuseppe Dattilo, Matteo Casale

Cor Vasa 2020, 62(3):332-335 | DOI: 10.33678/cor.2019.083  

Patent foramen ovale (PFO) is the most common structural cardiac anomaly associated with paradoxical embolism. Conditions increasing right heart chambers pressure, such as pulmonary embolism, can lead to its opening with increased risk of passage of thrombi from the venous to arterial circulation. Paradoxical embolism is a rare event with a possible severe prognosis. This case report is focused on a 77-year-old woman who was transported to the Emergency Department because of dyspnea, confusion, and chest pain with cardiogenic shock. The ECG showed a significant ST-T elevation in the high lateral leads. Both echocardiographic and clinical data suggested...

Usefulness of Sacubitril/Valsartan in reduction of atrial fibrillation burden in a patient with ICD delivering inappropriate therapies. A new possibility?

Matteo Casale, Maurizio Mezzetti, Marianna Gigliotti De Fazio, Marco Morelli, Loredana Caccamo, Paolo Busacca, Giuseppe Dattilo

Cor Vasa 2020, 62(3):336-339 | DOI: 10.33678/cor.2020.004  

Heart failure (HF) is currently a condition with high impact both in terms of clinical practice and of health care costs. Therapy with cardiac devices such as implantable cardioverter-defibrillators (ICD) is constantly evolving and often it is life-saving. However, in some cases it has minimal clinical impact on the symptoms. An optimal therapy is often not sufficient to avoid progression of the pathology, leading to arrhythmias such as atrial fibrillation, which could cause inappropriate delivery of therapies from the ICD. We describe the case of a patient with ICD who underwent cardiac evaluation in the Emergency Department because he experienced...

Mezinárodní konsenzus European Heart Rhythm Association (EHRA) o tom, jak předcházet infekcím implantabilních elektronických srdečních zařízení, diagnostikovat a léčit je.Souhrn dokumentu připravený Českou kardiologickou společností

Miloš Táborský, Josef Kautzner, Petr Neužil, Marián Fedorco, Hanka Wünschová, Lucie Šedivá, Jan Pyszko, Tomáš Skála, Jan Látal, Miroslav Novák, Milan Kozák, Lubomír Křivan, Vít Gloger, David Břečka, Milan Kolář

Cor Vasa 2020, 62(3):281-307 | DOI: 10.33678/cor.2020.059  

Authors of the original text:Carina Blomström-Lundqvist, Vassil TraykovPacemakers, implantable cardiac defibrillators, and cardiac resynchronization therapy devices are potentially life- -saving treatments for a number of cardiac conditions, but are not without risk. Most concerning is the risk of a cardiac implantable electronic device (CIED) infection, which is associated with significant morbidity, increased hospitalizations, reduced survival, and increased healthcare costs. Recommended preventive strategies such as administration of intravenous antibiotics before implantation are well recognized. Uncertainties have remained about the

(Expert consensus statement of the Czech Heart Failure Association of the Czech Society of Cardiology on the managing of heart failure clinics)

Filip Málek, Vojtěch Melenovský, Jan Krejčí, Aleš Linhart, Miloš Táborský, Lenka Špinarová, Jiří Vítovec, Jindřich Špinar, Radek Pudil, Jiří Veselý

Cor Vasa 2020, 62(3):309-313 | DOI: 10.33678/cor.2020.046  

This document deals with heart failure clinics that are established on all levels of cardiology centers and provide a specialized care of patients with heart failure.

Eulogy: Professor Milan Šamánek, DrSc, FESC (*09.05.1931 †29.04.2020) – legend from the East

Jan Marek, Jan Janoušek, Stanislav Tůma

Cor Vasa 2020, 62(3):341-342  

This article is to commemorate and celebrate achievements of Professor Milan Šamánek who passed away on 29th of April 2020. Milan was excellent and visionary paediatric cardiologist who helped to establish paediatric cardiology as a speciality in Czechoslovakia and several other east European countries in in the late 1970’s. Milan was also paramount for connecting the East and West, helping in no small way to establish the Association for European Paediatric Cardiology (AEPC) as the leading learned society in Europe.

K životnímu jubileu prof. MUDr. Jindřicha Špinara, CSc., FESC

Jiří Vítovec

Cor Vasa 2020, 62(3):343  

Richard Češka a kolektiv: Interna

Jan Petrášek

Cor Vasa 2020, 62(3):344